WCN25-3676 RESULTS FROM THE REGENCY TRIAL ASSESSING EFFICACY AND SAFETY OF OBINUTUZUMAB IN ACTIVE LUPUS NEPHRITIS
Saved in:
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-02-01
|
| Series: | Kidney International Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024924033825 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850223669130821632 |
|---|---|
| author | Brad Rovin Richard Furie Jay Garg Mittermanyer Santiago Gustavo Aroca-Martinez Adolfina Elizabeth Zuta Santillan Harini Raghu Imran Hassan Bongin Yoo Elsa Martins Himanshi Sehgal Theodore Omachi Thomas Schindler William Pendergraft Ana Malvar |
| author_facet | Brad Rovin Richard Furie Jay Garg Mittermanyer Santiago Gustavo Aroca-Martinez Adolfina Elizabeth Zuta Santillan Harini Raghu Imran Hassan Bongin Yoo Elsa Martins Himanshi Sehgal Theodore Omachi Thomas Schindler William Pendergraft Ana Malvar |
| author_sort | Brad Rovin |
| collection | DOAJ |
| format | Article |
| id | doaj-art-eee9dcaa092a431e951be1dcba017872 |
| institution | OA Journals |
| issn | 2468-0249 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Kidney International Reports |
| spelling | doaj-art-eee9dcaa092a431e951be1dcba0178722025-08-20T02:05:51ZengElsevierKidney International Reports2468-02492025-02-01102S771S77210.1016/j.ekir.2024.11.1360WCN25-3676 RESULTS FROM THE REGENCY TRIAL ASSESSING EFFICACY AND SAFETY OF OBINUTUZUMAB IN ACTIVE LUPUS NEPHRITISBrad Rovin0Richard Furie1Jay Garg2Mittermanyer Santiago3Gustavo Aroca-Martinez4Adolfina Elizabeth Zuta Santillan5Harini Raghu6Imran Hassan7Bongin Yoo8Elsa Martins9Himanshi Sehgal10Theodore Omachi11Thomas Schindler12William Pendergraft13Ana Malvar14Medicine, Ohio State University, Columbus, United StatesMedicine, Northwell, New York, United StatesMedicine, Genentech, Inc, South San Francisco, United StatesMedicine, Bahiana School of Medicine and Public Health, Salvador, BrazilMedicine, Universidad Simon Bolivar, Barranquilla, ColombiaGynecology, Instituto de Ginecologia y Reproduccion, Lima, PeruMedicine, Genentech, Inc, South San Francisco, United StatesMedicine, Hoffman-La Roche Ltd, Basel, SwitzerlandMedicine, Genentech, Inc, South San Francisco, United StatesMedicine, Hoffman-La Roche Ltd, Basel, SwitzerlandMedicine, Hoffman-La Roche Ltd, Basel, SwitzerlandMedicine, Genentech, Inc, South San Francisco, United StatesMedicine, Hoffman-La Roche Ltd, Basel, SwitzerlandMedicine, Genentech, Inc, South San Francisco, United StatesMedinine, Organizacion Medica de Investigacion, Buenos Aires, Argentinahttp://www.sciencedirect.com/science/article/pii/S2468024924033825 |
| spellingShingle | Brad Rovin Richard Furie Jay Garg Mittermanyer Santiago Gustavo Aroca-Martinez Adolfina Elizabeth Zuta Santillan Harini Raghu Imran Hassan Bongin Yoo Elsa Martins Himanshi Sehgal Theodore Omachi Thomas Schindler William Pendergraft Ana Malvar WCN25-3676 RESULTS FROM THE REGENCY TRIAL ASSESSING EFFICACY AND SAFETY OF OBINUTUZUMAB IN ACTIVE LUPUS NEPHRITIS Kidney International Reports |
| title | WCN25-3676 RESULTS FROM THE REGENCY TRIAL ASSESSING EFFICACY AND SAFETY OF OBINUTUZUMAB IN ACTIVE LUPUS NEPHRITIS |
| title_full | WCN25-3676 RESULTS FROM THE REGENCY TRIAL ASSESSING EFFICACY AND SAFETY OF OBINUTUZUMAB IN ACTIVE LUPUS NEPHRITIS |
| title_fullStr | WCN25-3676 RESULTS FROM THE REGENCY TRIAL ASSESSING EFFICACY AND SAFETY OF OBINUTUZUMAB IN ACTIVE LUPUS NEPHRITIS |
| title_full_unstemmed | WCN25-3676 RESULTS FROM THE REGENCY TRIAL ASSESSING EFFICACY AND SAFETY OF OBINUTUZUMAB IN ACTIVE LUPUS NEPHRITIS |
| title_short | WCN25-3676 RESULTS FROM THE REGENCY TRIAL ASSESSING EFFICACY AND SAFETY OF OBINUTUZUMAB IN ACTIVE LUPUS NEPHRITIS |
| title_sort | wcn25 3676 results from the regency trial assessing efficacy and safety of obinutuzumab in active lupus nephritis |
| url | http://www.sciencedirect.com/science/article/pii/S2468024924033825 |
| work_keys_str_mv | AT bradrovin wcn253676resultsfromtheregencytrialassessingefficacyandsafetyofobinutuzumabinactivelupusnephritis AT richardfurie wcn253676resultsfromtheregencytrialassessingefficacyandsafetyofobinutuzumabinactivelupusnephritis AT jaygarg wcn253676resultsfromtheregencytrialassessingefficacyandsafetyofobinutuzumabinactivelupusnephritis AT mittermanyersantiago wcn253676resultsfromtheregencytrialassessingefficacyandsafetyofobinutuzumabinactivelupusnephritis AT gustavoarocamartinez wcn253676resultsfromtheregencytrialassessingefficacyandsafetyofobinutuzumabinactivelupusnephritis AT adolfinaelizabethzutasantillan wcn253676resultsfromtheregencytrialassessingefficacyandsafetyofobinutuzumabinactivelupusnephritis AT hariniraghu wcn253676resultsfromtheregencytrialassessingefficacyandsafetyofobinutuzumabinactivelupusnephritis AT imranhassan wcn253676resultsfromtheregencytrialassessingefficacyandsafetyofobinutuzumabinactivelupusnephritis AT bonginyoo wcn253676resultsfromtheregencytrialassessingefficacyandsafetyofobinutuzumabinactivelupusnephritis AT elsamartins wcn253676resultsfromtheregencytrialassessingefficacyandsafetyofobinutuzumabinactivelupusnephritis AT himanshisehgal wcn253676resultsfromtheregencytrialassessingefficacyandsafetyofobinutuzumabinactivelupusnephritis AT theodoreomachi wcn253676resultsfromtheregencytrialassessingefficacyandsafetyofobinutuzumabinactivelupusnephritis AT thomasschindler wcn253676resultsfromtheregencytrialassessingefficacyandsafetyofobinutuzumabinactivelupusnephritis AT williampendergraft wcn253676resultsfromtheregencytrialassessingefficacyandsafetyofobinutuzumabinactivelupusnephritis AT anamalvar wcn253676resultsfromtheregencytrialassessingefficacyandsafetyofobinutuzumabinactivelupusnephritis |